Germany, Spain, and Italy conduct well-documented male-infertility stem-cell trials within university andrology and reproductive medicine departments. Poland and Czech Republic offer active protocols at lower cost structures. South Korea maintains several recruiting trials with published data. United States capacity is limited; a few academic fertility centres conduct investigational protocols. China conducts high-volume research, though regulatory transparency varies. Selection should prioritise centres with in-house andrology and reproductive medicine expertise, published outcomes, and ClinicalTrials.gov registration rather than standalone fertility marketing.
Male infertility stem-cell treatment costs typically range €4,000–7,500 per cycle, reflecting the need for testicular biopsy-guided injection or tissue regeneration protocols. Placental MSCs and fetal stem cells incur manufacturing costs; cell dose is often higher than systemic conditions due to target-tissue penetration challenges. Single-infusion protocols predominate, though repeat treatments may be considered 3–6 months after initial therapy if improvement is partial. Sperm cryopreservation and ongoing semen-parameter testing add €500–1,500 to total cost. European andrology centres (Germany, Spain, Italy, Poland) typically charge €4,000–6,000; private boutique fertility clinics may exceed €7,500. Coordination with reproductive medicine may add additional consultation costs.
Am I a candidate? → · Male Infertility: full overview → · Male Infertility cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Dr Dmytro Stoyanov (Urologist · 31+ yrs clinical practice) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite